Some aspects of medication and non-medication treatment of Alzheimer's disease
Медицинский совет, 2015 The article tells about a contemporary approach to the treatment of patients with Alzheimer's disease (AD). There are findings related to the effectiveness of the glutamate NMDA receptor antagonist memantine in AD, its effect on cognitive deficit ...
O. V. Kotova, E. S. Akarachkova
doaj +1 more source
Alzheimer’s disease with an early debut
Медицинский совет, 2019 The article reviews a clinical case of Alzheimer’s disease (AD) with early onset. This case study shows current approaches to the diagnosis of this form of AD and the management of this group of patients.
N. N. Koberskaya, N. A. Kovalchuk
doaj +1 more source
What predetermines the therapeutic tactics of a physician in the treatment of dementia? Results of a survey of Russian physicians [PDF]
, 2022 In order to study the point of view of doctors supervising patients with dementia regarding the methods and tactics of treating diseases that occur with severe cognitive impairment, their experience in the use of drugs and criteria for choosing a drug ...
A. V. Lukyanova +3 more
core +3 more sources
Медицинский совет, 2013 This literature review outlines the role of glutamatergic disturbances in the pathogenesis of cognitive disorders. There is data on the effectiveness of the glutamate NMDA-receptors antagonist - memantine - in patients with various dementias: Alzheimer's
I. S. Preobrazhenskaya
doaj +1 more source
Pathogenesis, diagnosis and treatment of Alzheimer's disease
Медицинский совет, 2015 The article is devoted to pathogenesis and diagnosis of Alzheimer's disease. The possibilities of treatment are discussed. Efficacy data for the basic symptomatic treatment of Alzheimer's disease, the potential and prospects of nootropic therapy are ...
A. A. Naumenko, I. S. Preobrazhenskaya
doaj +1 more source
Tolerability of antidementive therapy: results of observational research [PDF]
, 2018 Tere are 44 patients (5 males and 39 females), aged 56 to 90 years were included in the study. To assess the tolerability and safety of the drug, undesirable events were recorded, associated and not associated with taking the drugwith taking the drug, a ...
I. A. Beltceva +2 more
core +2 more sources
Результати клініко-економічного аналізу стану фармацевтичного забезпечення пацієнтів з деменцією внаслідок хвороби Альцгеймера в Україні [PDF]
, 2022 Aim. To conduct the clinical and economic analysis of the state of pharmaceutical provision of patients with dementia in Alzheimer’s disease in Ukraine. Materials and methods.
Chernukha, V. M. +7 more
core +2 more sources
ПОРІВНЯЛЬНА ОЦІНКА ВЕЛИЧИНИ АНТИАПОПТОТИЧНОГО ЕФЕКТУ СЕРЕД МОДУЛЯТОРІВ АКТИВНОСТІ NMDA-РЕЦЕПТОРІВ В УМОВАХ МОДЕЛЬНОЇ ПЕРЕХІДНОЇ ІШЕМІЇ РЕПЕРФУЗІЇ ОКА ЗА ДАНИМИ ПРОТОКОВО-ЦИТОМЕТРИЧНОГО АНАЛІЗУ [PDF]
, 2017 Experimental ischaemia-reperfusion in rat eyes, within 60 minutes, accompanied by activation of apoptotic processes in the retina, as evidenced by the increase in 20.22 times the number of cells that are in phase SUB-G0G1, i.e.
Khodakovskyi, A. A. +2 more
core +2 more sources
Management of patients with post-stroke dementia [PDF]
, 2013 Dementia occurs in 10-20% of cases and substantially hampers the rehabilitation of patients who have had stroke. Management of patients with post-stroke dementia is based on the prevention of recurrent stroke, cognitive stimulation, and the use of drugs ...
Svetlana Viktorovna Verbitskaya
core +2 more sources
Вплив модуляторів NMDA-рецепторів на біохімічні змінив сітківці при ішемічному та травматичному ураженні зорового аналізатора [PDF]
, 2018 Introduction. Glutamate exitotoxicity and hyperactivation of NMDA receptors play an important role in affecting the visual analyzer in cases of ischemia and trauma.
Povkh, V. L.
core +2 more sources